HEPARIN LOCK FLUSH

Pre-Launch

heparin sodium

Pfizer
NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
3

Clinical Trials (3)

NCT03113084Phase 1Suspended

Study With Heparin Sodium in Subcutaneous Administration

Started Aug 2022
NCT03125187Phase 1Suspended

Study With Heparin Sodium in Intravenous Administration

Started Feb 2021
NCT02181985Phase 3Completed

Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)

Started May 2000
5,989 enrolled
Myocardial Infarction
Company
Pfizer
Pfizer
NEW YORK, NY
614 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers